Cornerstone Therapeutics on track to achieve in excess of $8M in EKR synergies

theflyonthewall.com

CEO Craig A. Collard commented: "The integration of EKR Therapeutics was completed successfully and rapidly, well ahead of our plans, and we are on track to achieve in excess of $8 million in synergies during 2H of 2012. We plan to use our positive momentum to seek out additional acquisition opportunities to fuel our growth."

View Comments (0)